PMID- 35297063 OWN - NLM STAT- MEDLINE DCOM- 20220510 LR - 20220616 IS - 1537-2995 (Electronic) IS - 0041-1132 (Linking) VI - 62 IP - 5 DP - 2022 May TI - Relationship between allergic transfusion reactions and allergic predisposition among pediatric patients with hematological/oncological disease. PG - 1035-1044 LID - 10.1111/trf.16855 [doi] AB - BACKGROUND: Allergic transfusion reactions (ATRs) manifest frequently as transfusion reactions, and their onset may be related to a patient's allergic predisposition. Moreover, although pediatric patients with hematological/oncological disease are more susceptible to ATRs, the relationship between allergic predisposition and ATRs remains to be fully clarified. STUDY DESIGN AND METHODS: Patients who were diagnosed with pediatric hematological/oncological disease and received transfusion at the study institutions were included. We determined patient background information related to their allergy history, measured the levels of allergen-specific immunoglobulin E (IgE) using sera obtained on diagnosis, and analyzed their associations with ATR onset. RESULTS: Of the 363 patients analyzed, 144 developed ATRs. Multivariate analysis identified cases with high basophils in the peripheral blood, and Dermatophagoides pteronyssinus- and egg white-specific IgEs were involved in the development of ATR in all age groups. Meanwhile, a history of food allergies, and positivity for Japanese cypress- and D. pteronyssinus-specific IgEs were risk factors for developing ATRs in the <5 years age group. Moreover, patients aged 5-<10 years with a history of asthma, allergic rhinitis, pollinosis, or atopic dermatitis, and those aged >/=10 years with positivity for dog dander-specific IgE were at risk for developing ATRs. CONCLUSION: The allergic constitution of patients plays a role in ATR onset even in pediatric hematological/oncological diseases. Therefore, advance confirmation of a patient's allergic constitution may partly predict the onset of ATRs. However, since multiple allergic predispositions within complex mechanisms may be involved in the onset of ATRs, further verification is required. CI - (c) 2022 AABB. FAU - Yanagisawa, Ryu AU - Yanagisawa R AUID- ORCID: 0000-0003-4012-0958 AD - Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan. AD - Center for Advanced Cell Therapy, Shinshu University Hospital, Matsumoto, Japan. AD - Life Science Research Center, Nagano Children's Hospital, Azumino, Japan. FAU - Ishimine, Nau AU - Ishimine N AD - Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan. FAU - Komori, Kazutoshi AU - Komori K AD - Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan. FAU - Kurata, Takashi AU - Kurata T AD - Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan. FAU - Saito, Shoji AU - Saito S AD - Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. FAU - Tanaka, Miyuki AU - Tanaka M AD - Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. FAU - Sakashita, Kazuo AU - Sakashita K AD - Life Science Research Center, Nagano Children's Hospital, Azumino, Japan. AD - Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan. FAU - Tozuka, Minoru AU - Tozuka M AD - Life Science Research Center, Nagano Children's Hospital, Azumino, Japan. AD - Department of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan. FAU - Nakazawa, Yozo AU - Nakazawa Y AUID- ORCID: 0000-0003-0793-815X AD - Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. LA - eng PT - Journal Article DEP - 20220316 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Animals MH - Basophils MH - Child MH - Disease Susceptibility/complications MH - Dogs MH - Humans MH - *Hypersensitivity/etiology MH - Immunoglobulin E/analysis MH - Risk Factors MH - *Transfusion Reaction/complications OTO - NOTNLM OT - allergic rhinitis OT - allergic sensitization OT - asthma OT - atopic dermatitis OT - hay fever OT - pollinosis EDAT- 2022/03/18 06:00 MHDA- 2022/05/11 06:00 CRDT- 2022/03/17 05:35 PHST- 2022/02/03 00:00 [revised] PHST- 2021/12/14 00:00 [received] PHST- 2022/03/06 00:00 [accepted] PHST- 2022/03/18 06:00 [pubmed] PHST- 2022/05/11 06:00 [medline] PHST- 2022/03/17 05:35 [entrez] AID - 10.1111/trf.16855 [doi] PST - ppublish SO - Transfusion. 2022 May;62(5):1035-1044. doi: 10.1111/trf.16855. Epub 2022 Mar 16.